Related Experiment Video
Updated: Jun 2, 2025

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Childhood-onset inflammatory bowel disease and chronic non-bacterial osteomyelitis: a Swedish nationwide cohort study
Marianne Malmquist1,2, Siri Voghera3,
1Department of Pediatrics, Institute of Clinical Sciences, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Insights
Children with childhood-onset inflammatory bowel disease (IBD) have a significantly higher risk of developing chronic non-bacterial osteomyelitis (CNO). This study highlights key differences in patients with both IBD and CNO, including earlier onset and more frequent extraintestinal issues.
Area of Science:
- Pediatric Rheumatology
- Pediatric Gastroenterology
- Epidemiology
Background:
- Chronic non-bacterial osteomyelitis (CNO) is a rare condition.
- Population-based studies on CNO in childhood-onset inflammatory bowel disease (IBD) are scarce.
Purpose of the Study:
- To investigate the association between childhood-onset IBD and the risk of CNO.
- To compare clinical characteristics of IBD patients with and without CNO.
Main Methods:
- Utilized nationwide Swedish registers (2002-2022) to identify children with IBD and CNO.
- Employed Cox regression to analyze temporal associations between IBD and CNO.
- Compared clinical data between IBD patients with CNO (IBD+CNO) and those without CNO.
Main Results:
- Identified 8,244 children with IBD and 82,400 non-IBD comparators.
- Found a 6-fold increased risk of CNO in the IBD cohort (aHR=5.87).
- IBD+CNO patients had earlier IBD onset (median 11 vs 14 years), more extraintestinal manifestations (62% vs 21%), and higher biologic use (78% vs 44%).
Conclusions:
- Childhood-onset IBD is associated with a substantially increased risk of CNO.
- IBD patients who develop CNO present with distinct clinical features, including younger age at diagnosis and more comorbidities.
Background And Aims:
Nationwide, population-based studies of chronic non-bacterial osteomyelitis (CNO) in patients with childhood-onset inflammatory bowel disease (IBD) are lacking.
Methods:
We used nationwide registers to identify all children in Sweden diagnosed with IBD during 2002-2022 and the occurrence of CNO in this IBD cohort and general population non-IBD comparators. To estimate the temporal associations between IBD and CNO we used Cox regression. We compared clinical data for IBD patients with CNO (IBD+CNO) and the IBD patients without CNO.
Results:
We identified 8244 children with IBD and 82 400 non-IBD comparators. At IBD diagnosis, CNO had been diagnosed in 0.13% (11/8244) of the IBD cohort and 0.03% (26/82 400) of the non-IBD comparators. During follow-up, 13 additional CNO cases occurred in the IBD cohort and 22 in the non-IBD comparators (adjusted hazard ratio = 5.87 [95% CI 2.95-11.66]). The prevalence of CNO among all prevalent children with IBD and prevalent matched non-IBD comparators December 31, 2022 was 0.48% (9/1885) and 0.02% (4/18 567), respectively. Median age at IBD diagnosis was lower in IBD + CNO compared to IBD without CNO (11 vs 14 years [-3 years, 95% CI -5 to -1]). Extraintestinal manifestations (except CNO) were more frequent in IBD + CNO (62% vs 21%, P < .0001). Treatment with biologics was more common in the IBD + CNO group (78% vs 44%, P = .004), prescribed for IBD and/or CNO.
Conclusions:
We found a 6-fold increased risk of CNO in childhood-onset IBD compared to non-IBD comparators. Patients with IBD + CNO are characterized by younger age at IBD onset, more frequent extraintestinal manifestations, and higher usage of biologics.
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

